A carregar...
Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer
INTRODUCTION: Androgen deprivation therapy (ADT) is the mainstay for advanced, hormone-sensitive prostate cancer, and options include surgical castration, luteinizing hormone-releasing hormone (LHRH) agonist, and more recently, gonadotropin releasing hormone (GnRH) antagonist therapy. Our understand...
Na minha lista:
| Publicado no: | Expert Opin Pharmacother |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7171911/ https://ncbi.nlm.nih.gov/pubmed/28480768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14656566.2017.1328056 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|